BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8634463)

  • 1. Intrinsic coagulation, thrombosis, and bleeding.
    Kaplan AP
    Blood; 1996 Mar; 87(5):2090. PubMed ID: 8634463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disorders in the contact phase system of blood coagulation as a cause of increased partial thromboplastin time].
    Siegert G; Plat M
    Z Gesamte Inn Med; 1988 May; 43(9):228-31. PubMed ID: 3407236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
    Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion support for congenital clotting deficiencies other than haemophilia.
    Lewis JH; Spero JA; Ragni MV; Bontempo FA
    Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact factors in health and disease.
    Saito H
    Semin Thromb Hemost; 1987 Jan; 13(1):36-49. PubMed ID: 3551076
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation dynamics under the conditions of Hageman factor deficiency: a mathematical model.
    Obraztsov IF; Kuz'min VM; Khanin MA
    Dokl Biochem Biophys; 2002; 386():248-50. PubMed ID: 12469501
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact factors are responsible for the thrombogenicity of prothrombin complex.
    Chandra S; Wickerhauser M
    Thromb Res; 1979 Jan; 14(1):189-98. PubMed ID: 425079
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].
    Zeerleder S; Asmis L; Redondo M; Sulzer I; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):509-12. PubMed ID: 10517121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first cases of Fitzgerald factor deficiency in the Orient: three cases in one family.
    Hayashi H; Koya H; Kuroda M; Kitazima K; Kimura I; Katori M; Oh-ishi S
    Acta Haematol; 1980; 63(2):107-13. PubMed ID: 6768213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
    van Montfoort ML; Meijers JC
    Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.
    Colman RW; Schmaier AH
    Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis.
    Visser M; Heitmeier S; Ten Cate H; Spronk HMH
    Thromb Haemost; 2020 Jun; 120(6):883-993. PubMed ID: 32375196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
    Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minimal hemorrhagic diathesis].
    Huc N; Wijns W; Droeshout I; Capel P
    Rev Med Brux; 1992 Oct; 13(8):307-8. PubMed ID: 1439383
    [No Abstract]   [Full Text] [Related]  

  • 20. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
    Walsh PN; Griffin JH
    Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.